The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry

Recruiting now

Conditions studied: Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation

In brief

Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.

Key facts

Study ID

NCT04577248

Run by

Deutsches Herzzentrum Muenchen

People needed

5000

Starts

2020-09-15

Expected to finish

2031-01-01

Last updated by the study team

2020-10-08

Who can join

Age: 18 and older, up to 110. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age above 18 years and consentable
• Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis
• Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision
• Written informed consent

You may not qualify if…

• Patient's inability to fully cooperate with the protocol

Where it is running

• Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München — Munich, Bavaria, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.